Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cnossen

Showing results (291-300 of 442) with videos related to

Pageof 45
Sort By:
BMJ Open|May 5, 2018
Identifying Children with HEreditary Coagulation disorders (iCHEC): a protocol for a prospective cohort studyEva Stokhuijzen, Margaret L Rand, Marjon H Cnossen, et al.
Research and Practice in Thrombosis and Haemostasis|July 30, 2025
Health-related quality of life in rare bleeding disorders: results from the Rare Bleeding Disorders in the Netherlands studySterre P E Willems, Marjon H Cnossen, Nick van Es, et al.
Acta Neurochirurgica|December 21, 2018
Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI studyThomas A van Essen, Hugo F den Boogert, Maryse C Cnossen, et al.
Acta Neurochirurgica|February 5, 2019
Correction to: Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI studyThomas A van Essen, Hugo F den Boogert, Maryse C Cnossen, et al.
Research and Practice in Thrombosis and Haemostasis|January 16, 2026
Health care resources and costs associated with delivering gene therapy for hemophilia in clinical practiceDiaz M Prameyllawati, Caroline M A Mussert, Martijn A H Oude Voshaar, et al.
British Journal of Clinical Pharmacology|December 18, 2021
Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia ALaura H Bukkems, Lars L F G Valke, Wideke Barteling, et al.
American Journal of Hematology|September 17, 2015
Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleedingYvonne V Sanders, Karin Fijnvandraat, Johan Boender, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 28, 2015
Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experimentJ Lock, E W de Bekker-Grob, G Urhan, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 8, 2014
[Von Willebrand disease in the Netherlands: the WiN study]Yvonne V Sanders, Eva M de Wee, Karina Meijer, et al.
Hemoglobin|July 21, 2010
Codon 24 (TAT>TAG) and codon 32 (ATG>AGG) (Hb Rotterdam): two novel alpha2 gene mutations associated with mild alpha-thalassemia found in the same family after newborn screeningPiero C Giordano, Marjon H Cnossen, Annemarie M S Joosten, et al.
Pageof 45

Showing results (291-300 of 442) with videos related to

Sort By:
Pageof 45
BMJ Open|May 5, 2018
Identifying Children with HEreditary Coagulation disorders (iCHEC): a protocol for a prospective cohort studyEva Stokhuijzen, Margaret L Rand, Marjon H Cnossen, et al.
Research and Practice in Thrombosis and Haemostasis|July 30, 2025
Health-related quality of life in rare bleeding disorders: results from the Rare Bleeding Disorders in the Netherlands studySterre P E Willems, Marjon H Cnossen, Nick van Es, et al.
Acta Neurochirurgica|December 21, 2018
Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI studyThomas A van Essen, Hugo F den Boogert, Maryse C Cnossen, et al.
Acta Neurochirurgica|February 5, 2019
Correction to: Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI studyThomas A van Essen, Hugo F den Boogert, Maryse C Cnossen, et al.
Research and Practice in Thrombosis and Haemostasis|January 16, 2026
Health care resources and costs associated with delivering gene therapy for hemophilia in clinical practiceDiaz M Prameyllawati, Caroline M A Mussert, Martijn A H Oude Voshaar, et al.
British Journal of Clinical Pharmacology|December 18, 2021
Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia ALaura H Bukkems, Lars L F G Valke, Wideke Barteling, et al.
American Journal of Hematology|September 17, 2015
Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleedingYvonne V Sanders, Karin Fijnvandraat, Johan Boender, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 28, 2015
Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experimentJ Lock, E W de Bekker-Grob, G Urhan, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 8, 2014
[Von Willebrand disease in the Netherlands: the WiN study]Yvonne V Sanders, Eva M de Wee, Karina Meijer, et al.
Hemoglobin|July 21, 2010
Codon 24 (TAT>TAG) and codon 32 (ATG>AGG) (Hb Rotterdam): two novel alpha2 gene mutations associated with mild alpha-thalassemia found in the same family after newborn screeningPiero C Giordano, Marjon H Cnossen, Annemarie M S Joosten, et al.
Pageof 45